Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angela Brieger

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
Molecular Carcinogenesis|August 24, 2018
DNA mismatch repair activity of MutLα is regulated by CK2-dependent phosphorylation of MLH1 (S477)Isabel M Weßbecher, Inga Hinrichsen, Sebastian Funke, et al.
Molecular Cancer|January 25, 2014
Reduced migration of MLH1 deficient colon cancer cells depends on SPTAN1Inga Hinrichsen, Benjamin Philipp Ernst, Franziska Nuber, et al.
Nucleic Acids Research|May 24, 2023
A conserved motif in the disordered linker of human MLH1 is vital for DNA mismatch repair and its function is diminished by a cancer family mutationKarla Wolf, Jan Kosinski, Toby J Gibson, et al.
Leukemia & Lymphoma|September 14, 2004
In the erythroleukemic cell line HEL Prostate-apoptosis-response-gene-4 (par-4) fails to down-regulate Bcl-2 and to promote apoptosisSimone Boehrer, Angela Brieger, Simone Schaaf, et al.
Plos One|March 12, 2019
Downregulation of SPTAN1 is related to MLH1 deficiency and metastasis in colorectal cancerAnne Ackermann, Christopher Schrecker, Dimitra Bon, et al.
Biochemical Pharmacology|June 9, 2004
In bcr-abl-positive myeloid cells resistant to conventional chemotherapeutic agents, expression of Par-4 increases sensitivity to imatinib (STI571) and histone deacetylase-inhibitorsAngela Brieger, Simone Boehrer, Simone Schaaf, et al.
Leukemia & Lymphoma|September 17, 2004
Expression of ZAP-70 protein correlates with disease stage in chronic lymphocytic leukemia and is associated with, but not generally restricted to, non-mutated Ig VH statusSoo-Zin Kim, Kai Uwe Chow, Natasa Kukoc-Zivojnov, et al.
Carcinogenesis|December 6, 2014
Functional testing strategy for coding genetic variants of unclear significance in MLH1 in Lynch syndrome diagnosisInga Hinrichsen, Dieter Schäfer, Deborah Langer, et al.
Human Mutation|June 28, 2012
Comprehensive functional assessment of MLH1 variants of unknown significanceEster Borràs, Marta Pineda, Angela Brieger, et al.
Plos One|December 1, 2022
Functional characterization of MLH1 missense variants unveils mechanisms of pathogenicity and clarifies role in cancerMarwa Mahdouani, Slim Ben Ahmed, Fahmi Hmila, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
Molecular Carcinogenesis|August 24, 2018
DNA mismatch repair activity of MutLα is regulated by CK2-dependent phosphorylation of MLH1 (S477)Isabel M Weßbecher, Inga Hinrichsen, Sebastian Funke, et al.
Molecular Cancer|January 25, 2014
Reduced migration of MLH1 deficient colon cancer cells depends on SPTAN1Inga Hinrichsen, Benjamin Philipp Ernst, Franziska Nuber, et al.
Nucleic Acids Research|May 24, 2023
A conserved motif in the disordered linker of human MLH1 is vital for DNA mismatch repair and its function is diminished by a cancer family mutationKarla Wolf, Jan Kosinski, Toby J Gibson, et al.
Leukemia & Lymphoma|September 14, 2004
In the erythroleukemic cell line HEL Prostate-apoptosis-response-gene-4 (par-4) fails to down-regulate Bcl-2 and to promote apoptosisSimone Boehrer, Angela Brieger, Simone Schaaf, et al.
Plos One|March 12, 2019
Downregulation of SPTAN1 is related to MLH1 deficiency and metastasis in colorectal cancerAnne Ackermann, Christopher Schrecker, Dimitra Bon, et al.
Biochemical Pharmacology|June 9, 2004
In bcr-abl-positive myeloid cells resistant to conventional chemotherapeutic agents, expression of Par-4 increases sensitivity to imatinib (STI571) and histone deacetylase-inhibitorsAngela Brieger, Simone Boehrer, Simone Schaaf, et al.
Leukemia & Lymphoma|September 17, 2004
Expression of ZAP-70 protein correlates with disease stage in chronic lymphocytic leukemia and is associated with, but not generally restricted to, non-mutated Ig VH statusSoo-Zin Kim, Kai Uwe Chow, Natasa Kukoc-Zivojnov, et al.
Carcinogenesis|December 6, 2014
Functional testing strategy for coding genetic variants of unclear significance in MLH1 in Lynch syndrome diagnosisInga Hinrichsen, Dieter Schäfer, Deborah Langer, et al.
Human Mutation|June 28, 2012
Comprehensive functional assessment of MLH1 variants of unknown significanceEster Borràs, Marta Pineda, Angela Brieger, et al.
Plos One|December 1, 2022
Functional characterization of MLH1 missense variants unveils mechanisms of pathogenicity and clarifies role in cancerMarwa Mahdouani, Slim Ben Ahmed, Fahmi Hmila, et al.
Pageof 5